Stay updated on ReVive SE Device Clinical Trial
Sign up to get notified when there's something new on the ReVive SE Device Clinical Trial page.

Latest updates to the ReVive SE Device Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence,” and the site revision changes from v3.7.1 to v3.7.2. The study page itself still displays a 403 Forbidden error.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedAccess to the study record now shows a 403 Forbidden error, replacing the expected study details; the page layout (header, navigation, and footer) remains visible around the error message.SummaryDifference16%

- Check39 days agoChange DetectedThe page revision tag updates from v3.6.6 to v3.7.0, indicating an updated version of the study record on ClinicalTrials.gov.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page shows an updated revision number, changing from v3.6.5 to v3.6.6, indicating a small internal update rather than a substantive change to trial content.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page's revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the study record metadata rather than a change to the study details themselves. This update does not alter any study information or eligibility criteria.SummaryDifference0.1%

Stay in the know with updates to ReVive SE Device Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ReVive SE Device Clinical Trial page.